Quality by Design (QbD) and Analytical Methods - Webinar by GlobalCompliancePanel 2010
September 21, 2010(Ended)Online Webinar
As the industry is moving towards applying Quality by Design (QbD)
to process development, the question must be asked: Is this also the
way forward to revolutionise, improve and standardise our approach to
method development and qualification? The pharmaceutical industry has
traditionally controlled analytical methods via a well defined sequence
of development, validation and transfer exercises in line with agreed
standards such as the quality guidelines ICH Q2. Such an approach
limits the scope for technological innovation or improvements in
quality or efficiency of methods for established products. Applying
QbD would enable enhanced method understanding, and a more systematic
and scientific approach to development so that better controls may be
implemented. This 90 minute webinar looks at the how the QbD philosophy
can be applied to analytical methods, resulting in improved method
performance throughout the lifecycle of the method in terms of more
robust and rugged methods that are designed with the end user in mind.
A leaner science and risk based approach to method development and
qualification could emerge which would ultimately result in fewer
failures when new end users qualify a method and fewer OOS results for
routine methods. A QbD approach could move the process of analytical
method development and validation into a modern quality system of
continuous improvement. The webinar concludes with a comparison of the
traditional approach and a QbD approach to method development and
qualification.
Why should you attend: Do you like to keep up with current industry trends? Are you interested in the future of analytical method development and qualification? Are you curious to see how a QbD approach could also work for analytical methods? Would you like to see more robust methods resulting in fewer OOS results? If you answered yes to any of the above questions then this seminar is for you.
Areas Covered in the Session:
- Traditional approach (ICHQ2) and its weaknesses
- Definition of QbD
- Applying QbD to analytical methods
- Method design
- Method Understanding
- Design Space
- Continued method verification
- How this approach could help contract testing labs
- The benefits of a QbD approach
- Comparison of Traditional and QbD approach
Who Will Benefit:
- Laboratory Analysts
- Laboratory supervisors and managers
- Quality Assurance staff
- Regulatory Affairs staff
- Consultants
- Training Departments
- QbD fans
Prices *
245 US Dollar (Early registration date: August 20, 2010)
Exhibition
No exhibition
Organization
Categories
Concurrent events
- Why Medical Device Companies Receive Warning Letters - Webinar by GlobalCompliancePanel 2010
- Auditing Computer System Validation Materials - Webinar by GlobalCompliancePanel 2010
- ComplianceOnline Webinar - Medical Device Changes and The 510(k) 2010
- What are the “Good Clinical Practices” (GCP) of Research involving Human Subjects
- EU IMPD vs. US IND: Comparing the Content and Agency Expectations
- Service Level Agreements (SLAs) - Preparation Guidelines for Effective SLAs
- Developing Supplier Quality Auditor Training Programs
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Cancer Basic Research
- Business conference and trade shows as an efficient tool
- Business Events in the USA
- Aspects of business development through a business conference or exhibition
- Science conferences- learn for a better understanding of Science
- Medical conferences—establishing awareness in medical fields




